Find clinical trials for Glioblastoma (GBM) in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Glioblastoma (GBM) trials near New York, NY, USA:
FRONTIER Study is a prospective, interventional, single-arm, multi-center, study to assess the safety and technical feasibility of TheraSphere GBM...
Phase 1
New York, New York, United States and 8 other locations
efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...
Phase 1, Phase 2
New York, New York, United States and 20 other locations
(SOC) will improve survival in adult patients newly diagnosed with glioblastoma (IDH-wt). It will also evaluate the safety of DOC1021 + pIFN...
Phase 2
New York, New York, United States and 17 other locations
A Phase 1b/2, Multicenter, Open-Label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)...
Phase 1, Phase 2
New York, New York, United States and 6 other locations
This is a Phase 3 prospective, randomized, superiority, open-label, multi-site study. The overview of this study is as follows:* A Screening/Baseline...
Phase 3
Valhalla, New York, United States and 11 other locations
The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma...
Phase 2
New York, New York, United States and 30 other locations
This is an open-label, multicenter dose-escalation study to be followed by a dose expansion to define the optimal dose of GLIX1 as monotherapy by rev...
Phase 1
New York, New York, United States and 2 other locations
(MTA-based vaccine) in combination with standard care treatment of glioblastoma (GBM) and Tumor Treating Fields (TTFields).The stud...
Phase 1
The Bronx, New York, United States and 1 other location
This study will investigate different doses of \[177Lu\]Lu-NeoB in combination with RT and TMZ in participants with newly diagnosed glioblastoma...
Phase 1
New York, New York, United States and 15 other locations
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II...
Phase 2, Phase 3
New York, New York, United States and 62 other locations
Clinical trials
Research sites
Resources
Legal